Diagnosing nephrogenic systemic fibrosis in the post‐FDA restriction era

Publisher： John Wiley & Sons Inc

E-ISSN： 1522-2586|41|5|1268-1271

ISSN： 1053-1807

Source： JOURNAL OF MAGNETIC RESONANCE IMAGING, Vol.41, Iss.5, 2015-05, pp. : 1268-1271

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nephrogenic Systemic Fibrosis: More Questions and Some Answers

By  

Nephron Clin Pract, Vol. 110, Iss. 1, 2008-08 ,pp. : c24-c32

Karger

Access to resources Recommend Favorite

Perforating osteoma cutis in the setting of longstanding nephrogenic systemic fibrosis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : 571-572

John Wiley & Sons Inc

Access to resources Recommend Favorite

Nephrogenic systemic fibrosis in a gadolinium‐naïve patient: Successful treatment with oral sirolimus

By  

AUSTRALASIAN JOURNAL OF DERMATOLOGY, Vol. 56, Iss. 3, 2015-08 ,pp. : e59-e62

John Wiley & Sons Inc

Access to resources Recommend Favorite

Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis

By  

Current Drug Safety, Vol. 3, Iss. 1, 2008-01 ,pp. : 67-75

Bentham Science Publishers

Access to resources Recommend Favorite

Conventional or Gadolinium containing contrast media: the choice between acute renal failure or Nephrogenic Systemic Fibrosis?

By Grobner Thomas   Mayer Gert J.   Rosenkranz Alexander R.  

Wiener klinische Wochenschrift, Vol. 119, Iss. 9-10, 2007-06 ,pp. : 271-275

Springer Publishing Company

Access to resources Recommend Favorite